Aisyah Elliyanti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Aisyah Elliyanti has a total of 141 co-authors. Here are the top co-authors by number of shared publications:
Yulia Kurniawati
Nuclear Medicine Division of Radiology Department, Faculty of Medicine, Universitas Andalas, Padang, West Sumatra
5 shared publications- Dodi Safari
Eijkman Research Center for Molecular Biology, National Research and Innovation Agency, Cibinong, Indonesia
4 shared publications - Rosantia Sarassari
Eijkman Research Center for Molecular Biology, National Research and Innovation Agency (BRIN), Cibinong, West Java, Indonesia
4 shared publications Daan Khambri
Department of Surgery, Faculty of Medicine, Universitas Andalas / Dr. M. Djamil Hospital, Padang, 25163, Indonesia
3 shared publications- Dewi Anggraini
Department of Microbiology, Faculty of Medicine, Universitas Riau, Pekanbaru, Indonesia
3 shared publications - Adinda Elisabet
Department of Internal Medicine, Faculty of Medicine, Universitas Riau, Pekanbaru 28131, Indonesia
2 shared publications
Latest Publications
- Open Access
- 24 September 2026
- Published by Bentham Science Publishers Ltd. in The Open Dentistry Journal
- Vol. 20 (1)
Evaluation of the Setting Time and pH of Nanohydroxyapatite-Chitosan as a Direct Pulp Capping Material
Introduction/Objective: Calcium hydroxide (CaOH) and Mineral Trioxide Aggregate (MTA) are the most commonly used materials for Direct Pulp Capping (DPC). However, CaOH is associated with a very high pH and tunnel defects, whereas MTA has a prolonged setting time, potential tooth discoloration, low mechanical strength, and relatively high cost. Since setting time and pH are important physicochemical properties influencing clinical handling and pulp response, biocompatible alternatives are needed. Nanohydroxyapatite–Chitosan (nHA–CH) has shown potential to improve adhesion and promote dentin remineralization. Therefore, this study evaluated the setting time and pH of nHA–CH as a direct pulp capping material. Methods: An experimental laboratory study with a post-test-only control group design was conducted using nHA–CH, CaOH, and MTA (n = 6 per group). Setting time was measured using a Gillmore apparatus, and pH was measured after 3 and 24 hours using a digital pH meter. Data were analyzed using one-way ANOVA, post hoc LSD, and paired t-tests ( p < 0.05). Results: One-way ANOVA showed significant differences in setting time among the three materials ( p < 0.05). The mean setting times of nHA–CH, CaOH, and MTA were 15.32 ± 0.09, 2.51 ± 0.01, and 17.16 ± 0.03 min, respectively. Paired t-test analysis showed significant changes in pH between 3 and 24 hours for all materials ( p < 0.05). The pH of nHA–CH (6.90–7.27) remained lower than that of CaOH (10.33–11.51) and MTA (12.01–12.67). Discussion: The distinct setting and pH characteristics of nHA–CH suggest a potential balance between practical handling and a more pulp-compatible chemical environment, highlighting its potential as an alternative approach to direct pulp capping. Conclusion: nHA–CH demonstrated favorable gelation characteristics and a near-neutral to slightly alkaline pH; however, further studies are required before clinical application.
- 24 September 2026
- Published by Bentham Science Publishers Ltd. in The Open Dentistry Journal
- Vol. 20 (1)
Open AccessEvaluation of the Setting Time and pH of Nanohydroxyapatite-Chitosan as a Direct Pulp Capping Material
Introduction/Objective: Calcium hydroxide (CaOH) and Mineral Trioxide Aggregate (MTA) are the most commonly used materials for Direct Pulp Capping (DPC). However, CaOH is associated with a very high pH and tunnel defects, whereas MTA has a prolonged setting time, potential tooth discoloration, low mechanical strength, and relatively high cost. Since setting time and pH are important physicochemical properties influencing clinical handling and pulp response, biocompatible alternatives are needed. Nanohydroxyapatite–Chitosan (nHA–CH) has shown potential to improve adhesion and promote dentin remineralization. Therefore, this study evaluated the setting time and pH of nHA–CH as a direct pulp capping material. Methods: An experimental laboratory study with a post-test-only control group design was conducted using nHA–CH, CaOH, and MTA (n = 6 per group). Setting time was measured using a Gillmore apparatus, and pH was measured after 3 and 24 hours using a digital pH meter. Data were analyzed using one-way ANOVA, post hoc LSD, and paired t-tests ( p < 0.05). Results: One-way ANOVA showed significant differences in setting time among the three materials ( p < 0.05). The mean setting times of nHA–CH, CaOH, and MTA were 15.32 ± 0.09, 2.51 ± 0.01, and 17.16 ± 0.03 min, respectively. Paired t-test analysis showed significant changes in pH between 3 and 24 hours for all materials ( p < 0.05). The pH of nHA–CH (6.90–7.27) remained lower than that of CaOH (10.33–11.51) and MTA (12.01–12.67). Discussion: The distinct setting and pH characteristics of nHA–CH suggest a potential balance between practical handling and a more pulp-compatible chemical environment, highlighting its potential as an alternative approach to direct pulp capping. Conclusion: nHA–CH demonstrated favorable gelation characteristics and a near-neutral to slightly alkaline pH; however, further studies are required before clinical application.
- Open Access
- 10 June 2026
- Published by Scientific Scholar in Journal of King Saud University – Science
- Vol. 38, 18652025
Lactate dehydrogenase a in pulmonary arterial hypertension: From metabolic reprogramming to therapeutic targeting
Pulmonary arterial hypertension (PAH) is a progressive vascular disease marked by increased pulmonary arterial pressure leading to right ventricular overload and heart failure. Its pathogenesis involves vascular remodeling, characterized by an imbalance of vasoactive mediators, excessive endothelial and smooth muscle proliferation, and resistance to apoptosis. In the past decade, research has highlighted metabolic reprogramming, particularly aerobic glycolysis, as a central feature of PAH. This shift increases lactate concentration in the pulmonary artery (PA) as a byproduct of anaerobic glycolysis, largely influenced by lactate dehydrogenase A (LDH-A). LDH-A plays a pivotal role in vascular remodeling by regenerating nicotinamide adenine dinucleotide (NAD + ) to sustain glycolytic flux and drive pathological processes, including smooth muscle proliferation, endothelial dysfunction, and epigenetic modifications. LDH-A activates the phosphoinositide 3 kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway, a key regulator of cell growth, and induces hypoxia-inducible factor 1α (HIF 1α), which promotes endothelial to mesenchymal transition. Moreover, LDH-A enhances lactylation, an epigenetic modification that further stimulates cell proliferation. Given these mechanisms, LDH-A is considered a crucial factor in the progression of PAH. Its inhibition may represent a promising therapeutic target, with potential to reduce vascular remodeling and improve right ventricular function. Despite this, studies exploring LDH-A’s role in PAH remain limited, underscoring the need for further research to clarify its therapeutic potential.
- 10 June 2026
- Published by Scientific Scholar in Journal of King Saud University – Science
- Vol. 38, 18652025
Open AccessLactate dehydrogenase a in pulmonary arterial hypertension: From metabolic reprogramming to therapeutic targeting
Pulmonary arterial hypertension (PAH) is a progressive vascular disease marked by increased pulmonary arterial pressure leading to right ventricular overload and heart failure. Its pathogenesis involves vascular remodeling, characterized by an imbalance of vasoactive mediators, excessive endothelial and smooth muscle proliferation, and resistance to apoptosis. In the past decade, research has highlighted metabolic reprogramming, particularly aerobic glycolysis, as a central feature of PAH. This shift increases lactate concentration in the pulmonary artery (PA) as a byproduct of anaerobic glycolysis, largely influenced by lactate dehydrogenase A (LDH-A). LDH-A plays a pivotal role in vascular remodeling by regenerating nicotinamide adenine dinucleotide (NAD + ) to sustain glycolytic flux and drive pathological processes, including smooth muscle proliferation, endothelial dysfunction, and epigenetic modifications. LDH-A activates the phosphoinositide 3 kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway, a key regulator of cell growth, and induces hypoxia-inducible factor 1α (HIF 1α), which promotes endothelial to mesenchymal transition. Moreover, LDH-A enhances lactylation, an epigenetic modification that further stimulates cell proliferation. Given these mechanisms, LDH-A is considered a crucial factor in the progression of PAH. Its inhibition may represent a promising therapeutic target, with potential to reduce vascular remodeling and improve right ventricular function. Despite this, studies exploring LDH-A’s role in PAH remain limited, underscoring the need for further research to clarify its therapeutic potential.
- Open Access
- 28 April 2026
- Published by Universitas Negeri Semarang in Biosaintifika: Journal of Biology & Biology Education
- Vol. 18 (1) , 166-173
Antiproliferative and Apoptosis-Inducing Effects of Iodine Molecule in Differentiated Primary Thyroid Cancer Cells: In Vitro Study
Thyroid cancer poses a persistent clinical challenge, particularly when conventional therapies fall short. Growing evidence suggests that molecular iodine (I₂) may exert direct antitumor effects beyond its classical role in thyroid hormone synthesis. This study evaluated the antiproliferative and apoptosis-inducing effects of I₂ on primary cell cultures derived from differentiated thyroid cancer tissue and established dose- and time-response relationships. Primary cultures were exposed to I₂ at concentrations of 5, 10, 20, 40, 80, and 100 µM for 24, 48, and 72 hours. Cell viability was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, with IC₅₀ calculated accordingly. Apoptosis was characterized by acridine orange/propidium iodide (AO/PI) double-staining, analyzed by fluorescence microscopy and ImageJ software. I₂ demonstrated clear antiproliferative and apoptotic activity in a dose- and time-dependent manner. The strongest effect appeared at 100 µM after 72 hours, reducing viability to 1.39% (p < 0.001). At the IC₅₀ of 2.09 µM, iodine significantly suppressed proliferation and induced apoptosis, with an apoptosis rate of 81.77% ± 12.24% (p = 0.004). These findings confirm the meaningful antineoplastic potential of I₂ against differentiated thyroid cancer cells. This study supports SDG 3 (Good Health and Well-Being), contributing to efforts to develop more equitable, effective cancer treatment options and to reduce cancer-related morbidity globally.
- 28 April 2026
- Published by Universitas Negeri Semarang in Biosaintifika: Journal of Biology & Biology Education
- Vol. 18 (1) , 166-173
Open AccessAntiproliferative and Apoptosis-Inducing Effects of Iodine Molecule in Differentiated Primary Thyroid Cancer Cells: In Vitro Study
Thyroid cancer poses a persistent clinical challenge, particularly when conventional therapies fall short. Growing evidence suggests that molecular iodine (I₂) may exert direct antitumor effects beyond its classical role in thyroid hormone synthesis. This study evaluated the antiproliferative and apoptosis-inducing effects of I₂ on primary cell cultures derived from differentiated thyroid cancer tissue and established dose- and time-response relationships. Primary cultures were exposed to I₂ at concentrations of 5, 10, 20, 40, 80, and 100 µM for 24, 48, and 72 hours. Cell viability was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, with IC₅₀ calculated accordingly. Apoptosis was characterized by acridine orange/propidium iodide (AO/PI) double-staining, analyzed by fluorescence microscopy and ImageJ software. I₂ demonstrated clear antiproliferative and apoptotic activity in a dose- and time-dependent manner. The strongest effect appeared at 100 µM after 72 hours, reducing viability to 1.39% (p < 0.001). At the IC₅₀ of 2.09 µM, iodine significantly suppressed proliferation and induced apoptosis, with an apoptosis rate of 81.77% ± 12.24% (p = 0.004). These findings confirm the meaningful antineoplastic potential of I₂ against differentiated thyroid cancer cells. This study supports SDG 3 (Good Health and Well-Being), contributing to efforts to develop more equitable, effective cancer treatment options and to reduce cancer-related morbidity globally.
- Open Access
- 31 March 2026
- Published by Korean Society for Preventive Medicine in Journal of Preventive Medicine and Public Health
- Vol. 59 (2) , 110-122
Patient Education to Reduce Anxiety Among Cancer Patients Undergoing Radiotherapy Procedure: A Systematic Review of Interventional Studies
Objectives: Nearly 1 in 3 cancer patients undergoing radiotherapy experience anxiety, which can negatively affect both quality of life and prognosis. This systematic review aimed to synthesize evidence on patient education and its impact on anxiety levels among cancer patients undergoing radiotherapy.Methods: We conducted a systematic review of the current literature using 3 scientific databases—PubMed, EBSCOhost, and Web of Science—to identify intervention studies. Data were analyzed using a narrative synthesis approach, integrating findings across studies to draw comprehensive conclusions.Results: Fifteen studies involving 1988 participants were included. Baseline anxiety levels, measured using various instruments, ranged from 2.9% to 88.2% before radiotherapy and declined thereafter in both intervention and control groups. Most studies reported no significant difference in anxiety reduction between intervention groups receiving educational programs and control groups receiving standard education. However, interventions that were more intensive and delivered by professional staff were more likely to produce statistically significant reductions in anxiety.Conclusions: This review suggests that patient education remains relevant for reducing anxiety among cancer patients undergoing radiotherapy. Routine screening for anxiety prior to radiotherapy is recommended, along with the development of more intensive and tailored educational interventions rather than passive or minimal approaches.
- 31 March 2026
- Published by Korean Society for Preventive Medicine in Journal of Preventive Medicine and Public Health
- Vol. 59 (2) , 110-122
Open AccessPatient Education to Reduce Anxiety Among Cancer Patients Undergoing Radiotherapy Procedure: A Systematic Review of Interventional Studies
Objectives: Nearly 1 in 3 cancer patients undergoing radiotherapy experience anxiety, which can negatively affect both quality of life and prognosis. This systematic review aimed to synthesize evidence on patient education and its impact on anxiety levels among cancer patients undergoing radiotherapy.Methods: We conducted a systematic review of the current literature using 3 scientific databases—PubMed, EBSCOhost, and Web of Science—to identify intervention studies. Data were analyzed using a narrative synthesis approach, integrating findings across studies to draw comprehensive conclusions.Results: Fifteen studies involving 1988 participants were included. Baseline anxiety levels, measured using various instruments, ranged from 2.9% to 88.2% before radiotherapy and declined thereafter in both intervention and control groups. Most studies reported no significant difference in anxiety reduction between intervention groups receiving educational programs and control groups receiving standard education. However, interventions that were more intensive and delivered by professional staff were more likely to produce statistically significant reductions in anxiety.Conclusions: This review suggests that patient education remains relevant for reducing anxiety among cancer patients undergoing radiotherapy. Routine screening for anxiety prior to radiotherapy is recommended, along with the development of more intensive and tailored educational interventions rather than passive or minimal approaches.
- Open Access
- 29 January 2026
- Published by Universitas Andalas in JOURNAL OBGIN EMAS
- Vol. 10 (1) , 58-69
The Role of Transforming Growth Factor Beta (TGF-β) in Pelvic Organ Prolapse : A Systematic Review
Introduction: Pelvic organ prolapse (POP) is a gynaecological disorder with a rising prevalence, significantly affecting quality of life. While the pathogenesis of POP is multifactorial, alterations in the extracellular matrix (ECM) have been implicated, particularly the role of transforming growth factor-beta (TGF-β) in ECM remodelling. However, the precise relationship between TGF-β and POP remains unclear. Methods: A systematic review was conducted following PRISMA guidelines. Relevant studies were identified from PubMed, Scopus, Web of Science, and the Cochrane Library. Inclusion criteria focused on studies investigating TGF-β expression in women with POP. Data extraction included study design, patient demographics, TGF-β detection methods, and key findings. Results: Analysis of nine studies revealed mixed findings. Four studies reported a significant reduction in TGF-β1 expression in POP patients, suggesting impaired ECM regulation via the TGF-β1/Smad3 pathway. Three studies found no significant differences in TGF-β levels between POP and control groups, while one study linked increased TGF-β1 levels to severe prolapse, possibly as a compensatory response. Variations in methodology, sample size, and patient characteristics contributed to inconsistencies across studies. Conclusion: Current evidence suggests that TGF-β1 plays a role in POP pathogenesis, with lower levels potentially weakening ECM integrity and higher levels in advanced cases reflecting a failed reparative response. Further research is needed to explore TGF-β interactions with other biomarkers and assess its potential as a therapeutic target.
- 29 January 2026
- Published by Universitas Andalas in JOURNAL OBGIN EMAS
- Vol. 10 (1) , 58-69
Open AccessThe Role of Transforming Growth Factor Beta (TGF-β) in Pelvic Organ Prolapse : A Systematic Review
Introduction: Pelvic organ prolapse (POP) is a gynaecological disorder with a rising prevalence, significantly affecting quality of life. While the pathogenesis of POP is multifactorial, alterations in the extracellular matrix (ECM) have been implicated, particularly the role of transforming growth factor-beta (TGF-β) in ECM remodelling. However, the precise relationship between TGF-β and POP remains unclear. Methods: A systematic review was conducted following PRISMA guidelines. Relevant studies were identified from PubMed, Scopus, Web of Science, and the Cochrane Library. Inclusion criteria focused on studies investigating TGF-β expression in women with POP. Data extraction included study design, patient demographics, TGF-β detection methods, and key findings. Results: Analysis of nine studies revealed mixed findings. Four studies reported a significant reduction in TGF-β1 expression in POP patients, suggesting impaired ECM regulation via the TGF-β1/Smad3 pathway. Three studies found no significant differences in TGF-β levels between POP and control groups, while one study linked increased TGF-β1 levels to severe prolapse, possibly as a compensatory response. Variations in methodology, sample size, and patient characteristics contributed to inconsistencies across studies. Conclusion: Current evidence suggests that TGF-β1 plays a role in POP pathogenesis, with lower levels potentially weakening ECM integrity and higher levels in advanced cases reflecting a failed reparative response. Further research is needed to explore TGF-β interactions with other biomarkers and assess its potential as a therapeutic target.
- Open Access
- 1 January 2026
- Published by XMLink in Infection & Chemotherapy
- Vol. 58 (2) , 214-223
Metagenomic Analysis of Thoracic Empyema Etiology Through Next-Generation Sequencing Enhances Conventional Culture Techniques
This study aimed to analyze the microbiome of thoracic empyema using metagenomic methods and compare the results with conventional culture methods to increase diagnostic accuracy and enhance antibiotic therapy. This study involved 30 patients with thoracic empyema from hospitals in Riau Province, Indonesia. Pleural fluid samples were collected for culture analysis and identification using the Vitek 2 compact system and metagenomic analysis. Patient clinical data were also collected. Culture methods showed a 40.0% positive rate, with Gram-negative bacteria (Klebsiella pneumoniae and Pseudomonas aeruginosa) predominating. Metagenomics showed a 56.7% positive rate, identifying a more diverse microbiome, including fungi (29.4% abundance), other Gram-negative bacteria (26.5%), and anaerobic bacteria (22.5%). Comparison of the two methods showed 36.7% complete agreement and 23.3% partial agreement, with 40% disagreement, with a Kappa coefficient of 0.416 and P-value of 0.016 (P<0.050). Metagenomic NGS offers significant advantages in detecting the microbiome of thoracic empyema, particularly fungi and anaerobic bacteria, which are often missed by conventional culture methods. This has the potential to improve diagnostic accuracy and optimize antibiotic therapy. Further research with larger sample sizes is needed.
- 1 January 2026
- Published by XMLink in Infection & Chemotherapy
- Vol. 58 (2) , 214-223
Open AccessMetagenomic Analysis of Thoracic Empyema Etiology Through Next-Generation Sequencing Enhances Conventional Culture Techniques
This study aimed to analyze the microbiome of thoracic empyema using metagenomic methods and compare the results with conventional culture methods to increase diagnostic accuracy and enhance antibiotic therapy. This study involved 30 patients with thoracic empyema from hospitals in Riau Province, Indonesia. Pleural fluid samples were collected for culture analysis and identification using the Vitek 2 compact system and metagenomic analysis. Patient clinical data were also collected. Culture methods showed a 40.0% positive rate, with Gram-negative bacteria (Klebsiella pneumoniae and Pseudomonas aeruginosa) predominating. Metagenomics showed a 56.7% positive rate, identifying a more diverse microbiome, including fungi (29.4% abundance), other Gram-negative bacteria (26.5%), and anaerobic bacteria (22.5%). Comparison of the two methods showed 36.7% complete agreement and 23.3% partial agreement, with 40% disagreement, with a Kappa coefficient of 0.416 and P-value of 0.016 (P<0.050). Metagenomic NGS offers significant advantages in detecting the microbiome of thoracic empyema, particularly fungi and anaerobic bacteria, which are often missed by conventional culture methods. This has the potential to improve diagnostic accuracy and optimize antibiotic therapy. Further research with larger sample sizes is needed.
- Open Access
- 23 December 2025
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
The Determinant Analysis of Adverse Maternal and Neonatal Outcomes in Pregnancy with Pre-existing Heart Disease
Background: Pregnancy complicated by maternal heart disease remains a leading cause of morbidity and mortality for both mothers and neonates. However, information regarding the factors influencing cardiovascular events in neonates and mothers within 6 months postpartum is limited. This study aimed to identify predictors of adverse maternal and neonatal outcomes in pregnancies of women with pre-existing heart disease. Methods: The study conducted a retrospective cross-sectional analysis of all pregnancies with a history of heart disease from January 2017 to January 2024, using secondary data from medical records at Dr M. Djamil Padang Hospital, Indonesia. We analysed the data using the χ2/Fisher’s exact test and logistic regression. Results: A total of 110 pregnant women with heart diseases were hospitalised during the study period, with an average age of 30.52 ± 6.00 years. The most common types of heart disease were valvular heart disease (28%), chronic hypertension (24%) and congenital heart disease (23%). In 27.2% of cases, adverse maternal outcomes included mortality (10%), heart failure (8.2%), arrhythmia (4.5%), rehospitalisation (3.6%) and thromboembolic event (0.9%). Meanwhile, 57.3% of cases had neonatal adverse outcomes, including mortality (5.4%), low Apgar score (16.4%), prematurity (28.2%), low birthweight (6.4%) and congenital heart disease (0.9%). The multivariate analysis discovered that moderate-to-severe left heart obstruction (OR 14.184; 95% CI [2.725–73.836]; p=0.002) and reduced ejection fraction <40% (OR 16.211; 95% CI [1.712–153.507]; p=0.015) were the main factors that led to adverse maternal outcomes. Meanwhile, cyanotic congenital heart disease (OR 8.449; 95% CI [1.030-69.328]; p=0.047) was the most important determinant of adverse neonatal outcomes. Conclusion: This study revealed that moderate-severe left heart obstruction and reduced ejection fraction <40% were the most significant factors influencing adverse maternal outcomes. Meanwhile, cyanotic congenital heart disease was the most important determinant of adverse neonatal outcomes.
- 23 December 2025
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
Open AccessThe Determinant Analysis of Adverse Maternal and Neonatal Outcomes in Pregnancy with Pre-existing Heart Disease
Background: Pregnancy complicated by maternal heart disease remains a leading cause of morbidity and mortality for both mothers and neonates. However, information regarding the factors influencing cardiovascular events in neonates and mothers within 6 months postpartum is limited. This study aimed to identify predictors of adverse maternal and neonatal outcomes in pregnancies of women with pre-existing heart disease. Methods: The study conducted a retrospective cross-sectional analysis of all pregnancies with a history of heart disease from January 2017 to January 2024, using secondary data from medical records at Dr M. Djamil Padang Hospital, Indonesia. We analysed the data using the χ2/Fisher’s exact test and logistic regression. Results: A total of 110 pregnant women with heart diseases were hospitalised during the study period, with an average age of 30.52 ± 6.00 years. The most common types of heart disease were valvular heart disease (28%), chronic hypertension (24%) and congenital heart disease (23%). In 27.2% of cases, adverse maternal outcomes included mortality (10%), heart failure (8.2%), arrhythmia (4.5%), rehospitalisation (3.6%) and thromboembolic event (0.9%). Meanwhile, 57.3% of cases had neonatal adverse outcomes, including mortality (5.4%), low Apgar score (16.4%), prematurity (28.2%), low birthweight (6.4%) and congenital heart disease (0.9%). The multivariate analysis discovered that moderate-to-severe left heart obstruction (OR 14.184; 95% CI [2.725–73.836]; p=0.002) and reduced ejection fraction <40% (OR 16.211; 95% CI [1.712–153.507]; p=0.015) were the main factors that led to adverse maternal outcomes. Meanwhile, cyanotic congenital heart disease (OR 8.449; 95% CI [1.030-69.328]; p=0.047) was the most important determinant of adverse neonatal outcomes. Conclusion: This study revealed that moderate-severe left heart obstruction and reduced ejection fraction <40% were the most significant factors influencing adverse maternal outcomes. Meanwhile, cyanotic congenital heart disease was the most important determinant of adverse neonatal outcomes.
- Open Access
- 3 December 2025
- Published by Universitas Sriwijaya (Relawan) in Jurnal Penelitian Sains
- Vol. 27 (3) , 1-10
Optimalisasi Terapi Radioaktif Yodium (RAI) pada Kanker Tiroid: Tinjauan Literatur
Optimalisasi Terapi Radioaktif Yodium (RAI) pada Kanker Tiroid: Tinjauan Literatur
- 3 December 2025
- Published by Universitas Sriwijaya (Relawan) in Jurnal Penelitian Sains
- Vol. 27 (3) , 1-10
Open AccessOptimalisasi Terapi Radioaktif Yodium (RAI) pada Kanker Tiroid: Tinjauan Literatur
Optimalisasi Terapi Radioaktif Yodium (RAI) pada Kanker Tiroid: Tinjauan Literatur
- 2 November 2025
- Published by Marmara University in Journal of Research in Pharmacy
- Vol. 29 (6) , 2386-2394
Amelioration of cisplatin-induced ototoxicity by thymoquinone in male Wistar rats
Cisplatin is effective against cancer but has serious ototoxicity side effects. Thymoquinone has been shown to be a powerful antioxidant and anti-inflammatory, and it has scavenging activity against free radicals. This study aims to determine the effects of thymoquinone on superoxide dismutase (SOD), malondialdehyde acid (MDA), and nuclear factor kappa-B (NF-κB) levels; signal-to-noise ratio (SNR) value of distortion product otoacoustic emission (DPOAE); and degree of outer hair cells (OHC) damage in cisplatin ototoxicity. This experimental animal study included 24 healthy male Wistar rats (Rattus norvegicus), which were divided into four groups. Group 1 was the positive control that received cisplatin alone; Groups 2 and 3 received cisplatin (15 mg/kg BW) and thymoquinone at different doses (25 mg/kg/day for Group 2 and 50 mg/kg/day for Group 3); and Group 4 was the negative control. SOD levels were measured using a colorimetric assay; MDA levels with a thiobarbituric acid reactive substances (TBAR) assay; NF-κB levels with an enzyme-linked immunosorbent assay (ELISA); SNR values with a DPOAE examination; and histopathology examination was performed after treatment to determine the effects of thymoquinone on reducing the ototoxicity of cisplatin. The mean of MDA and NF-κB levels and OHC damage increased significantly in Group compared to Group 4. The mean of SOD levels and SNR values of DPOAE decreased significantly in Group 1 compared to Group 4. The administration of cisplatin and thymoquinone at 50 mg/kg/day resulted in a significant increase in SOD level and SNR value of DPOAE and a significant decrease in MDA levels, NF-κB, and degree of OHC damage compared with Group 1, with p < 0.05. Thymoquinone administration reduced the ototoxicity of cisplatin by improving SOD levels and SNR values of DPOAE and decreasing MDA, NF-κB levels, and the degree of OHC damage.
- 2 November 2025
- Published by Marmara University in Journal of Research in Pharmacy
- Vol. 29 (6) , 2386-2394
Amelioration of cisplatin-induced ototoxicity by thymoquinone in male Wistar rats
Cisplatin is effective against cancer but has serious ototoxicity side effects. Thymoquinone has been shown to be a powerful antioxidant and anti-inflammatory, and it has scavenging activity against free radicals. This study aims to determine the effects of thymoquinone on superoxide dismutase (SOD), malondialdehyde acid (MDA), and nuclear factor kappa-B (NF-κB) levels; signal-to-noise ratio (SNR) value of distortion product otoacoustic emission (DPOAE); and degree of outer hair cells (OHC) damage in cisplatin ototoxicity. This experimental animal study included 24 healthy male Wistar rats (Rattus norvegicus), which were divided into four groups. Group 1 was the positive control that received cisplatin alone; Groups 2 and 3 received cisplatin (15 mg/kg BW) and thymoquinone at different doses (25 mg/kg/day for Group 2 and 50 mg/kg/day for Group 3); and Group 4 was the negative control. SOD levels were measured using a colorimetric assay; MDA levels with a thiobarbituric acid reactive substances (TBAR) assay; NF-κB levels with an enzyme-linked immunosorbent assay (ELISA); SNR values with a DPOAE examination; and histopathology examination was performed after treatment to determine the effects of thymoquinone on reducing the ototoxicity of cisplatin. The mean of MDA and NF-κB levels and OHC damage increased significantly in Group compared to Group 4. The mean of SOD levels and SNR values of DPOAE decreased significantly in Group 1 compared to Group 4. The administration of cisplatin and thymoquinone at 50 mg/kg/day resulted in a significant increase in SOD level and SNR value of DPOAE and a significant decrease in MDA levels, NF-κB, and degree of OHC damage compared with Group 1, with p < 0.05. Thymoquinone administration reduced the ototoxicity of cisplatin by improving SOD levels and SNR values of DPOAE and decreasing MDA, NF-κB levels, and the degree of OHC damage.
- Open Access
- 25 October 2025
- Published by Universitas Andalas in Majalah Kedokteran Andalas
- Vol. 48 (4) , 457-465
Potensi Terapeutik Tanaman Andalas (Morus macroura Miq.) sebagai Sumber Antioksidan dan Antiinflamasi : Narrative Review
Latar Belakang: Tanaman Andalas (Morus macroura Miq.) merupakan salah satu tanaman asli Indonesia yang dianggap sebagai maskot Sumatera Barat. Tanaman herbal ini kaya akan senyawa bioaktif. Tujuan: Mengetahui potensi terapeutik dan preventif tanaman andalas sebagai sumber antioksidan dan antiinflamasi. Metode: Pendekatan narrative review, sumber literatur dari Pubmed, Google Scholar, dan Science Direct. Penulis menggunakan kata kunci Morus macroura Miq. atau andalas, potensi terapeutik, antioksidan, antiinflamasi. Kriteria inklusi berupa artikel sesuai dengan tema penelitian, artikel terindeks scopus, serta diterbitkan tahun 2019-2023. Kriteria eksklusi meliputi artikel yang tidak dapat diakses, tidak menjawab jenis review. Hasil: Tanaman andalas berpotensi sebagai antioksidan dengan cara mengurangi indeks stres oksidatif dan meningkatkan pertahanan antioksidan. Tanaman andalas juga berpotensi sebagai antiinflamasi dengan cara menurukan kadar biomarker peradangan dan meningkatkan ekspresi miRNA-223. Kesimpulan: Tanaman andalas berpotensi sebagai sumber antioksidan dan antiinflamasi serta agen terapeutik yang menjanjinkan dalam pengobatan penyakit terkait inflamasi dan stres oksidatif, seperti kolitis ulserativa, kanker, neurotoksisitas, dan lainnya yang memerlukan uji klinis lebih lanjut.
- 25 October 2025
- Published by Universitas Andalas in Majalah Kedokteran Andalas
- Vol. 48 (4) , 457-465
Open AccessPotensi Terapeutik Tanaman Andalas (Morus macroura Miq.) sebagai Sumber Antioksidan dan Antiinflamasi : Narrative Review
Latar Belakang: Tanaman Andalas (Morus macroura Miq.) merupakan salah satu tanaman asli Indonesia yang dianggap sebagai maskot Sumatera Barat. Tanaman herbal ini kaya akan senyawa bioaktif. Tujuan: Mengetahui potensi terapeutik dan preventif tanaman andalas sebagai sumber antioksidan dan antiinflamasi. Metode: Pendekatan narrative review, sumber literatur dari Pubmed, Google Scholar, dan Science Direct. Penulis menggunakan kata kunci Morus macroura Miq. atau andalas, potensi terapeutik, antioksidan, antiinflamasi. Kriteria inklusi berupa artikel sesuai dengan tema penelitian, artikel terindeks scopus, serta diterbitkan tahun 2019-2023. Kriteria eksklusi meliputi artikel yang tidak dapat diakses, tidak menjawab jenis review. Hasil: Tanaman andalas berpotensi sebagai antioksidan dengan cara mengurangi indeks stres oksidatif dan meningkatkan pertahanan antioksidan. Tanaman andalas juga berpotensi sebagai antiinflamasi dengan cara menurukan kadar biomarker peradangan dan meningkatkan ekspresi miRNA-223. Kesimpulan: Tanaman andalas berpotensi sebagai sumber antioksidan dan antiinflamasi serta agen terapeutik yang menjanjinkan dalam pengobatan penyakit terkait inflamasi dan stres oksidatif, seperti kolitis ulserativa, kanker, neurotoksisitas, dan lainnya yang memerlukan uji klinis lebih lanjut.